全文获取类型
收费全文 | 14933篇 |
免费 | 1373篇 |
国内免费 | 64篇 |
专业分类
耳鼻咽喉 | 200篇 |
儿科学 | 341篇 |
妇产科学 | 225篇 |
基础医学 | 1977篇 |
口腔科学 | 215篇 |
临床医学 | 1513篇 |
内科学 | 3219篇 |
皮肤病学 | 378篇 |
神经病学 | 929篇 |
特种医学 | 604篇 |
外科学 | 2555篇 |
综合类 | 108篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 1247篇 |
眼科学 | 509篇 |
药学 | 1111篇 |
中国医学 | 83篇 |
肿瘤学 | 1151篇 |
出版年
2023年 | 151篇 |
2022年 | 122篇 |
2021年 | 691篇 |
2020年 | 449篇 |
2019年 | 550篇 |
2018年 | 638篇 |
2017年 | 423篇 |
2016年 | 502篇 |
2015年 | 518篇 |
2014年 | 653篇 |
2013年 | 703篇 |
2012年 | 1117篇 |
2011年 | 1086篇 |
2010年 | 645篇 |
2009年 | 516篇 |
2008年 | 897篇 |
2007年 | 880篇 |
2006年 | 748篇 |
2005年 | 698篇 |
2004年 | 616篇 |
2003年 | 537篇 |
2002年 | 493篇 |
2001年 | 491篇 |
2000年 | 449篇 |
1999年 | 363篇 |
1998年 | 105篇 |
1997年 | 86篇 |
1996年 | 80篇 |
1995年 | 75篇 |
1994年 | 66篇 |
1993年 | 58篇 |
1992年 | 148篇 |
1991年 | 103篇 |
1990年 | 118篇 |
1989年 | 107篇 |
1988年 | 92篇 |
1987年 | 79篇 |
1986年 | 65篇 |
1985年 | 54篇 |
1984年 | 47篇 |
1983年 | 32篇 |
1982年 | 19篇 |
1981年 | 11篇 |
1980年 | 14篇 |
1979年 | 15篇 |
1978年 | 6篇 |
1977年 | 10篇 |
1976年 | 8篇 |
1975年 | 7篇 |
1974年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
101.
Chen M Gavrilova O Zhao WQ Nguyen A Lorenzo J Shen L Nackers L Pack S Jou W Weinstein LS 《The Journal of clinical investigation》2005,115(11):3217-3227
The G protein G(s)alpha is essential for hormone-stimulated cAMP generation and is an important metabolic regulator. We investigated the role of liver G(s)-signaling pathways by developing mice with liver-specific G(s)alpha deficiency (LGsKO mice). LGsKO mice had increased liver weight and glycogen content and reduced adiposity, whereas survival, body weight, food intake, and metabolic rates at ambient temperature were unaffected. LGsKO mice had increased glucose tolerance with both increased glucose-stimulated insulin secretion and increased insulin sensitivity in liver and muscle. Fed LGsKO mice were hypoglycemic and hypoinsulinemic, with low expression of hepatic gluconeogenic enzymes and PPARgamma coactivator-1. However, LGsKO mice maintained normal fasting glucose and insulin levels, probably due to prolonged breakdown of glycogen stores and possibly increased extrahepatic gluconeogenesis. Lipid metabolism was unaffected in fed LGsKO mice, but fasted LGsKO mice had increased lipogenic and reduced lipid oxidation gene expression in liver and increased serum triglyceride and FFA levels. LGsKO mice had very high serum glucagon and glucagon-like peptide-1 levels and pancreatic alpha cell hyperplasia, probably secondary to hepatic glucagon resistance and/or chronic hypoglycemia. Our results define novel roles for hepatic G(s)-signaling pathways in glucose and lipid regulation, which may prove useful in designing new therapeutic targets for diabetes and obesity. 相似文献
102.
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract 总被引:20,自引:0,他引:20
Brenchley JM Schacker TW Ruff LE Price DA Taylor JH Beilman GJ Nguyen PL Khoruts A Larson M Haase AT Douek DC 《The Journal of experimental medicine》2004,200(6):749-759
The mechanisms underlying CD4(+) T cell depletion in human immunodeficiency virus (HIV) infection are not well understood. Comparative studies of lymphoid tissues, where the vast majority of T cells reside, and peripheral blood can potentially illuminate the pathogenesis of HIV-associated disease. Here, we studied the effect of HIV infection on the activation and depletion of defined subsets of CD4(+) and CD8(+) T cells in the blood, gastrointestinal (GI) tract, and lymph node (LN). We also measured HIV-specific T cell frequencies in LNs and blood, and LN collagen deposition to define architectural changes associated with chronic inflammation. The major findings to emerge are the following: the GI tract has the most substantial CD4(+) T cell depletion at all stages of HIV disease; this depletion occurs preferentially within CCR5(+) CD4(+) T cells; HIV-associated immune activation results in abnormal accumulation of effector-type T cells within LNs; HIV-specific T cells in LNs do not account for all effector T cells; and T cell activation in LNs is associated with abnormal collagen deposition. Taken together, these findings define the nature and extent of CD4(+) T cell depletion in lymphoid tissue and point to mechanisms of profound depletion of specific T cell subsets related to elimination of CCR5(+) CD4(+) T cell targets and disruption of T cell homeostasis that accompanies chronic immune activation. 相似文献
103.
Beatriz Rodriguez-Grande Matimba Swana Loan Nguyen Pavlos Englezou Samaneh Maysami Stuart M Allan Nancy J Rothwell Cecilia Garlanda Adam Denes Emmanuel Pinteaux 《Journal of cerebral blood flow and metabolism》2014,34(3):480-488
Acute-phase proteins (APPs) are key effectors of the immune response and are routinely used as biomarkers in cerebrovascular diseases, but their role during brain inflammation remains largely unknown. Elevated circulating levels of the acute-phase protein pentraxin-3 (PTX3) are associated with worse outcome in stroke patients. Here we show that PTX3 is expressed in neurons and glia in response to cerebral ischemia, and that the proinflammatory cytokine interleukin-1 (IL-1) is a key driver of PTX3 expression in the brain after experimental stroke. Gene deletion of PTX3 had no significant effects on acute ischemic brain injury. In contrast, the absence of PTX3 strongly compromised blood–brain barrier integrity and resolution of brain edema during recovery after ischemic injury. Compromised resolution of brain edema in PTX3-deficient mice was associated with impaired glial scar formation and alterations in scar-associated extracellular matrix production. Our results suggest that PTX3 expression induced by proinflammatory signals after ischemic brain injury is a critical effector of edema resolution and glial scar formation. This highlights the potential role for inflammatory molecules in brain recovery after injury and identifies APPs, in particular PTX3, as important targets in ischemic stroke and possibly other brain inflammatory disorders. 相似文献
104.
Sawako Unezaki Tayo Katano Takeshi Y. Hiyama Nguyen H. Tu Satoru Yoshii Masaharu Noda Seiji Ito 《The European journal of neuroscience》2014,39(5):720-729
Nax, a sodium concentration‐sensitive sodium channel, is expressed in non‐myelinating Schwann cells of the adult peripheral nervous system, but the pathophysiological role remains unclear. We found that functional recovery of the hind paw responses from the sciatic nerve transection was delayed in Nax knockout ( ) mice. Histological analyses showed a decrease in the number of regenerated myelinated axons in sciatic nerves. The delay in the recovery in mice was improved by lactate and inhibited by a monocarboxylate transporter inhibitor. In vitro experiments using cultured Schwann cells showed that lactate release was enhanced by endothelin (ET)‐1 and blocked by an ET receptor type B antagonist. Here, it is conceivable that Nax was activated by ET‐1. The amount of lactate release by ET‐1 was lower in mice than in wild‐type mice. These results indicated that Nax is functionally coupled to ET for lactate release via ET receptor type B and is involved in peripheral nerve regeneration. 相似文献
105.
Philippe Alix Kumar Venkatesan Jacqueline Scuvée‐Moreau Laurent Massotte Mai‐Linh Nguyen Trung Charlotte A. Cornil Vincent Seutin 《The European journal of neuroscience》2014,39(2):186-196
Most serotonergic neurons display a prominent medium‐duration afterhyperpolarization (mAHP), which is mediated by small‐conductance Ca2+‐activated K+ (SK) channels. Recent ex vivo and in vivo experiments have suggested that SK channel blockade increases the firing rate and/or bursting in these neurons. The purpose of this study was therefore to characterize the source of Ca2+ which activates the mAHP channels in serotonergic neurons. In voltage‐clamp experiments, an outward current was recorded at ?60 mV after a depolarizing pulse to +100 mV. A supramaximal concentration of the SK channel blockers apamin or (‐)‐bicuculline methiodide blocked this outward current. This current was also sensitive to the broad Ca2+ channel blocker Co2+ and was partially blocked by both ω‐conotoxin and mibefradil, which are blockers of N‐type and T‐type Ca2+ channels, respectively. Neither blockers of other voltage‐gated Ca2+ channels nor DBHQ, an inhibitor of Ca2+‐induced Ca2+ release, had any effect on the SK current. In current‐clamp experiments, mAHPs following action potentials were only blocked by ω‐conotoxin and were unaffected by mibefradil. This was observed in slices from both juvenile and adult rats. Finally, when these neurons were induced to fire in an in vivo‐like pacemaker rate, only ω‐conotoxin was able to increase their firing rate (by ~30%), an effect identical to the one previously reported for apamin. Our results demonstrate that N‐type Ca2+ channels are the only source of Ca2+ which activates the SK channels underlying the mAHP. T‐type Ca2+ channels may also activate SK channels under different circumstances. 相似文献
106.
Amy D. Nguyen Katy Slack Christoph Schwarzer Nicola J. Lee Dana Boey Laurence Macia Ernie Yulyaningsih Ronaldo F. Enriquez Lei Zhang Shu Lin Yan-Chuan Shi Paul A. Baldock Herbert Herzog Amanda Sainsbury 《Neuropeptides》2014
Objective
Orexigenic neuropeptide Y (NPY) and dynorphin (DYN) regulate energy homeostasis. Single NPY or dynorphin deletion reduces food intake or increases fat loss. Future developments of obesity therapeutics involve targeting multiple pathways. We hypothesised that NPY and dynorphin regulate energy homeostasis independently, thus double NPY and dynorphin ablation would result in greater weight and/or fat loss than the absence of NPY or dynorphin alone.Design and methods
We generated single and double NPY and dynorphin knockout mice (NPYΔ, DYNΔ, NPYDYNΔ) and compared body weight, adiposity, feeding behaviour, glucose homeostasis and brown adipose tissue uncoupling protein-1 (UCP-1) expression to wildtype counterparts.Results
Body weight and adiposity were significantly increased in NPYDYNΔ, but not in NPYΔ or DYNΔ. This was not due to increased food intake or altered UCP-1 expression, which were not significantly altered in double knockouts. NPYDYNΔ mice demonstrated increased body weight loss after a 24-h fast, with no effect on serum glucose levels after glucose injection.Conclusions
Contrary to the predicted phenotype delineated from single knockouts, double NPY and dynorphin deletion resulted in heavier mice, with increased adiposity, despite no significant changes in food intake or UCP-1 activity. This indicates that combining long-term opioid antagonism with blockade of NPY-ergic systems may not produce anti-obesity effects. 相似文献107.
Praful Ravi Pierre I. Karakiewicz Florian Roghmann Giorgio Gandaglia Toni K. Choueiri Mani Menon Rana R. McKay Paul L. Nguyen Jesse D. Sammon Shyam Sukumar Briony Varda Steven L. Chang Adam S. Kibel Maxine Sun Quoc-Dien Trinh 《Urologic oncology》2014,32(8):1333-1340
ObjectiveTo examine the burden of mental health issues (MHI), namely anxiety, depressive disorders, and suicide, in a population-based cohort of older men with localized prostate cancer and to evaluate associations with primary treatment modality.Patients and methodsA total of 50,856 men, who were 65 years of age or older with clinically localized prostate cancer diagnosed between 1992 and 2005 and without a diagnosis of mental illness at baseline, were abstracted from the Surveillance, Epidemiology, and End Results–Medicare database. The primary outcome of interest was the development of MHI (anxiety, major depressive disorder, depressive disorder not elsewhere classified, neurotic depression, adjustment disorder with depressed mood, and suicide) after the diagnosis of prostate cancer.ResultsA total of 10,389 men (20.4%) developed MHI during the study period. Independent risk factors for MHI included age≥75 years (hazard ratio [HR] = 1.29); higher comorbidity (Charlson comorbidity index≥3, HR = 1.63); rural hospital location (HR = 1.14); being single, divorced, or widowed (HR = 1.12); later year of diagnosis (HR = 1.05); and urinary incontinence (HR = 1.47). Black race (HR = 0.79), very high-income status (HR = 0.87), and definitive treatment (radical prostatectomy [RP], HR = 0.79; radiotherapy [RT], HR= 0.85, all P<0.001) predicted a lower risk of MHI. The rates of MHI at 10 years were 29.7%, 29.0%, and 22.6% in men undergoing watchful waiting (WW), RT, and RP, respectively.ConclusionOlder men with localized prostate cancer had a significant burden of MHI. Men treated with RP or RT were at a lower risk of developing MHI, compared with those undergoing WW, with median time to development of MHI being significantly greater in those undergoing RP compared with those undergoing RT or WW. 相似文献
108.
Brandon A. Mahal David R. Ziehr Ayal A. Aizer Andrew S. Hyatt Jesse D. Sammon Marianne Schmid Toni K. Choueiri Jim C. Hu Christopher J. Sweeney Clair J. Beard Anthony V. D׳Amico Neil E. Martin Christopher Lathan Simon P. Kim Quoc-Dien Trinh Paul L. Nguyen 《Urologic oncology》2014,32(8):1285-1291
ObjectivesTreating high-risk prostate cancer (CaP) with definitive therapy improves survival. We evaluated whether having health insurance reduces racial disparities in the use of definitive therapy for high-risk CaP.Materials and methodsThe Surveillance, Epidemiology, and End Results Program was used to identify 70,006 men with localized high-risk CaP (prostate-specific antigen level >20 ng/ml or Gleason score 8–10 or stage>cT3a) diagnosed from 2007 to 2010. We used multivariable logistic regression to analyze the 64,277 patients with complete data to determine the factors associated with receipt of definitive therapy.ResultsCompared with white men, African American (AA) men were significantly less likely to receive definitive treatment (adjusted odds ratio [AOR] = 0.60; 95% CI: 0.56–0.64; P<0.001) after adjusting for sociodemographics and known CaP prognostic factors. There was a significant interaction between race and insurance status (Pinteraction = 0.01) such that insurance coverage was associated with a reduction in racial disparity between AA and white patients regarding receipt of definitive therapy. Specifically, the AOR for definitive treatment for AA vs. white was 0.38 (95% CI: 0.27–0.54, P<0.001) among uninsured men, whereas the AOR was 0.62 (95% CI: 0.57–0.66, P<0.001) among insured men.ConclusionsAA men with high-risk CaP were significantly less likely to receive potentially life-saving definitive treatment when compared with white men. Having health insurance was associated with a reduction in this racial treatment disparity, suggesting that expansion of health insurance coverage may help reduce racial disparities in the management of aggressive cancers. 相似文献
109.
Regulatory T cells (Tregs) are essential for the establishment and maintenance of immune tolerance, suggesting a potential therapeutic role for Tregs in transplantation. However, Treg administration alone is insufficient in inducing long‐term allograft survival in normal hosts, likely due to the high frequency of alloreactive T cells. We hypothesized that a targeted reduction of alloreactive T effector cells would allow a therapeutic window for Treg efficacy. Here we show that preconditioning recipient mice with donor‐specific transfusion followed by cyclophosphamide treatment deleted 70–80% donor‐reactive T cells, but failed to prolong islet allograft survival. However, infusion of either 5 × 106 Tregs with direct donor reactivity or 25 × 106 polyclonal Tregs led to indefinite survival of BALB/c islets in more than 70% of preconditioned C57BL/6 recipients. Notably, protection of C3H islets in autoimmune nonobese diabetic mice required islet autoantigen‐specific Tregs together with polyclonal Tregs. Treg therapy led to significant reduction of CD8+ T cells and concomitant increase in endogenous Tregs among graft‐infiltrating cells early after transplantation. Together, these results demonstrate that reduction of the donor‐reactive T cells will be an important component of Treg‐based therapies in transplantation. 相似文献
110.